Recombinant CTNNB1 antibody
Quick Overview for Recombinant CTNNB1 antibody (ABIN6939211)
Target
See all CTNNB1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    - 
                                            Immunogen
- Recombinant full-length human β-catenin protein
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        Positive Control: HeLa or MCF-7 cells. Breast carcinoma. Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL),Western Blot (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined. 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Concentration
- 200 μg/mL
- 
                                            Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- 4 °C,-80 °C
- 
                                            Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- 
                                            Expiry Date
- 24 months
 
- 
                                            
- 
    - CTNNB1 (Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1))
- 
                                            Alternative Name
- CTNNB1
- 
                                            Background
- Beta-catenin associates with the cytoplasmic portion of E-cadherin, which is necessary for the function of E-cadherin as an adhesion molecule. In normal tissues, beta-catenin is localized to the membrane of epithelial cells, consistent with its role in the cell adhesion complex. In breast ductal neoplasia, beta-catenin is usually localized in cellular membranes. However, in lobular neoplasia, a marked redistribution of beta-catenin throughout the cytoplasm results in a diffuse cytoplasmic pattern. Immuno-staining of beta-catenin and E-cadherin is helps in the accurate identification of ductal and lobular neoplasms, including a distinction between low-grade ductal carcinoma in situ (DCIS) and lobular carcinoma. Additionally, some rectal and gastric adenocarcinomas demonstrate diffuse cytoplasmic beta-catenin staining and a lack of membranous staining, mimicking the staining pattern observed with lobular breast carcinomas.
- 
                                            Molecular Weight
- 92kDa
- 
                                            Gene ID
- 1499
- 
                                            UniProt
- P35222
- 
                                            Pathways
- WNT Signaling, Intracellular Steroid Hormone Receptor Signaling Pathway, Peptide Hormone Metabolism, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Tube Formation, Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2
 Target
- 
                    
 
                                     
                                     
                                    